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Abstract
Background: The dystonias include a clinically and etiologically very diverse group of disorders. There are both degenerative and non-degenerative subtypes
resulting from genetic or acquired causes. Traditionally, all dystonias have been viewed as disorders of the basal ganglia. However, there has been increasing
appreciation for involvement of other brain regions including the cerebellum, thalamus, midbrain, and cortex. Much of the early evidence for these other brain
regions has come from studies of animals, but multiple recent studies have been done with humans, in an effort to confirm or refute involvement of these other
regions. The purpose of this article is to review the new evidence from animals and humans regarding the motor network model, and to address the issues important
to translational neuroscience.
Methods: The English literature was reviewed for articles relating to the neuroanatomical basis for various types of dystonia in both animals and humans.
Results: There is evidence from both animals and humans that multiple brain regions play an important role in various types of dystonia. The most direct evidence
for specific brain regions comes from animal studies using pharmacological, lesion, or genetic methods. In these studies, experimental manipulations of specific brain
regions provide direct evidence for involvement of the basal ganglia, cerebellum, thalamus and other regions. Additional evidence also comes from human studies
using neuropathological, neuroimaging, non-invasive brain stimulation, and surgical interventions. In these studies, the evidence is less conclusive, because
discriminating the regions that cause dystonia from those that reflect secondary responses to abnormal movements is more challenging.
Discussion: Overall, the evidence from both animals and humans suggests that different regions may play important roles in different subtypes of dystonia. The
evidence so far provides strong support for the motor network model. There are obvious challenges, but also advantages, of attempting to translate knowledge
gained from animals into a more complete understanding of human dystonia and novel therapeutic strategies.
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Introduction
The dystonias include a group of disorders with diverse clinical
manifestations.1 They may first emerge in infants, or in older adults.
They may affect virtually any region of the body, alone or in various
combinations. Their evolution over time also varies, with subtypes that
are acute onset and static, others that are slowly progressive, and some
that progress in stepwise fashion or appear episodic. Etiologically, the
dystonias are also quite diverse.2,3 Genetic and acquired causes are
recognized, but many cases are idiopathic. Some subtypes are associated
with static focal lesions of the brain, others show degenerative changes, and
many have no apparent brain pathology. This clinical and etiological
heterogeneity is important when considering their biological underpinnings.
Although the dystonias are grouped together on the basis of their
motor manifestations, pathogenesis may differ among the subtypes.
For example, it is likely that the biological processes responsible for
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causing early-onset childhood generalized dystonias differ from those
that cause late-onset focal dystonias. Clear differences in pathogenesis
have been identified among certain early-onset dystonias,4 late-onset
focal dystonias,5 and inherited versus acquired dystonias.6 The simi-
larities and differences in the pathogenesis of different subtypes of
dystonia are important when considering the development of new
therapies.7,8
Traditionally, the dystonias were viewed as disorders of the basal
ganglia, but there has been increasing appreciation for involvement of
other brain regions. Considering the etiological heterogeneity, the
involvement of different brain regions is not surprising. The evidence
suggesting involvement of different regions was first summarized in a
comprehensive review in 2011 that encompassed the historical context,
basic neuroanatomy, clinical observations, and experimental results
from animals and humans.9 Collectively, the evidence suggested a
motor network model in which different types of dystonia might be
caused by defects in different brain regions. Since then, numerous
additional studies evaluating the motor network model have been
published, along with multiple reviews and commentaries.10–17
The purpose of the current review is to summarize some of the more
recent evidence regarding the neuroanatomical basis for the dystonias.
Additional evidence from animal studies has now provided unequi-
vocal evidence that the basal ganglia or cerebellum can independently
play a causal role for specific types of dystonia. Additional evidence has
been obtained from human studies also, but a causal role for specific
brain regions has been more challenging to establish. A major reason
for the limitations of the human studies is that studies required to prove
causation usually cannot be conducted. This review addresses the
challenge of translating results from basic sciences involving animal
studies into a more complete understanding of human dystonia, and to
consider how this translation might impact therapeutic strategies.
Methods
The PubMed database was reviewed to find English language
articles relevant to the neuroanatomical basis for dystonia. Various
terms commonly used to describe dystonia (dystonic, torticollis, bleph-
arospasm, Meige, writer’s cramp) were combined with anatomical
terms (basal ganglia, putamen, caudate, globus pallidus, pallidum,
cerebellum, dentate, thalamus, cortex, midbrain, brainstem, magnetic
resonance imaging [MRI], pathology, histopathology). The citations
provided in these articles were also reviewed. More than 200 articles
were reviewed. Because a comprehensive review of this topic has been
published,9 the emphasis here was on the more recent articles, and
especially those that addressed the neuroanatomical basis.
The anatomical basis for dystonia: evidence from rodents
Historical perspective. Animal studies have provided the most direct
evidence regarding specific brain regions responsible for dystonia.
The earliest studies were summarized previously,9 and those that
are most relevant to neuroanatomical localization are listed in Table 1.
For example, a role for the basal ganglia has been established by
showing that selective lesions of the striatum with the neurotoxin
3-nitropropionic acid can cause dystonia in rodents.18,19 A role for the
cerebellum has been established by genetic models of dystonia such as
the dt rat20,21 or the tottering mouse,22,23 and by pharmacological studies
showing activation of cerebellar glutamate receptors can cause dystonia
in normal mice.24 Other animal studies have pointed to abnormal inter-
actions among different motor control centers.25,26
Since then, additional studies have provided further evidence that
dystonia may arise from selective dysfunction of the basal ganglia or
cerebellum, or combined dysfunction of multiple regions. These new
studies are divided below into pharmacological and genetic models,
focusing on those that are most directly relevant to anatomical
localization.
Pharmacological rodent models. Animal models that involve micro-
injection of specific drugs into selected brain regions are valuable
because they can pinpoint neurochemical processes in specific brain
regions that may be responsible for their effect.27 Because the basal
ganglia are accepted as a source for dystonia, most of the newer studies
have focused on other regions. Early studies showing that direct
pharmacological activation of cerebellar glutamate receptors can cause
dystonia in mice24 have now been replicated by independent labo-
ratories.28–30 The phenomenon appears to be partly topographically
organized, such that injection of glutamate agonists into the cerebellar
midline cause axial dystonia, while injections into the hemispheres are
more likely to cause limb dystonia. The effect is mediated by sustained
activation of the a-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
(AMPA) subtype of glutamate receptors in the cerebellum and does not
appear to require the basal ganglia.25
Another study showed that silencing olivocerebellar glutamatergic
synapses via genetic methods can cause dystonia in mice.31 In this
model, dystonia is associated with abnormal physiological activity
of cerebellar Purkinje neurons and their target neurons in the deep
cerebellar nuclei. Deep brain stimulation (DBS) directed to the deep
cerebellar nuclei blocks dystonia, providing strong evidence for
involvement of cerebellar pathways in this model.
Other studies have used a pharmacological approach to model
rapid-onset dystonia–parkinsonism, which in humans is caused by
mutations in the sodium–potassium pump encoded by the ATP1A3
gene (DYT12). This pump is widely expressed in the brain, but
pharmacological inhibition with ouabain injections directly into the
cerebellum can cause dystonia in normal mice.32 This effect results
from the drug’s ability to induce abnormally persistent high-frequency
burst-firing of cerebellar Purkinje neurons.33 Dystonic movements are
thought to arise because the abnormal output from these cerebellar
Purkinje neurons disrupts signaling in the basal ganglia.34 In a related
study, dystonia also emerged after knocking down expression of the
same pump directly in the cerebellum with short hairpin RNAs.35 This
model supports a mechanism in which a defect beginning in the cerebellum
can produce dystonia by disrupting the function of the basal ganglia.
Genetic rodent models. Genetic rodent models are attractive because
they can provide information on the functions of a gene associa-
ted with dystonia in humans.36 One recently described model is a
Jinnah HA, Neychev V, Hess EJ Motor Network Model for Dystonia
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services2
genetically engineered mouse for dopa-responsive dystonia.37 In this
model, a point mutation affecting tyrosine hydroxylase that causes
dopa-responsive dystonia in humans was introduced into mice. In mice
carrying this mutation, the mutation caused a diurnal pattern of
abnormal movements with clinical and electrophysiological hallmarks
of human dystonia. The abnormal movements could be reduced with
either peripheral or direct intrastriatal administration of levodopa,
directly implicating basal ganglia dopamine signaling.
The Gunn rat model of kernicterus also displays early-onset gene-
ralized dystonia that has been linked with dysfunction of the basal
Table 1. Rodent Models with Dystonic Motor Phenotype
Genetic models Gene Gene Product Phenotype Biological Basis
for Dystonia
Tottering mouse Cacna1a a1a subunit of P/Q-type
calcium channel
Paroxysmal generalized
dystonia with mild ataxia
Abnormal cerebellar
Purkinje neuron activity











DRD mouse TH Tyrosine hydroxylase Diurnal dystonia Reduced striatal
dopamine




















Blepharospasm rat 6-OHDA Lesion of nigral neurons
combined with partial








Oubain Inhibition of cerebellar
sodium/potassium pump
by local microinjection










Generalized dystonia Abnormal cerebellar
Purkinje neuron activity
Levodopa-induced




Trunk and limb dystonia Abnormal striatal neuron
activity
3-nitroproionic acid
lesions (mouse or rat)
3-Nitroproionic acid Lesions of striatum by local
or systemic injections




1,3-di-o-Tolylguanidine Microinjection into the
red nucleus
Generalized dystonia Abnormal rubral neuron
activity
This table selectively includes rodent models where the anatomical origin of dystonia has been well studied. It does not include many models where
the anatomical source for dystonia has not been clearly established, or genetic models with no apparent dystonic motor phenotype.
Abbreviations: 6-OHDA, 6-Hydroxydopamine; AMPA, a-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid.
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ganglia.38 In this model, electrophysiological recordings have revealed
abnormal output from the basal ganglia, and focal lesions of the basal
ganglia cause dystonic movements.
Other genetic models have implicated the cerebellum. The CACNA1A
gene encodes a calcium channel that is widely expressed in the human
brain and associated with numerous different clinical phenotypes
including episodic or progressive ataxia, migraine with or without
hemiplegia, epilepsy, dystonia, and others.39 Several mouse mutants
harbor different mutations in the same gene, and they have equally
varied phenotypes. Different mutations cause paroxysmal dystonia in
the tottering and rocker mutants,23,40 or generalized dystonia in leaner,
wobbly, and knockout mutants.41,42 In the tottering mutants, selective
expression of the mutant gene in only Purkinje neurons is sufficient to
cause paroxysmal dystonia. The severity of dystonia is related to the
percentage of abnormal Purkinje neurons. In the leaner mutants, age-
related degeneration of Purkinje cells is accompanied by transformation of
a dystonic phenotype into an ataxic phenotype. Additionally, mutations of
the Ip3r1 gene that disrupt intracellular calcium signaling are also
associated with dystonia that originates from the cerebellum.43 The results
from these studies imply that dystonia results from abnormal signaling by
cerebellar Purkinje neurons, not loss of these neurons.
One of the best-studied genetic animal models is based on the
TOR1A gene that is responsible for DYT1 dystonia in humans.
Although the brain appears grossly normal in the majority of the
transgenic and knock-in mice, careful histological studies have
revealed microstructural defects in both the striatum44 and the
cerebellum.45–47 MRI studies have similarly implied microstructural
defects in both areas.48–50 Physiological studies have revealed
functional abnormalities in striatal cholinergic neuron signaling,51–57
and neurochemical studies have revealed striking defects in striatal
dopamine release.58–61 On the other hand, metabolic studies impli-
cate prominent functional disturbances of cerebellar pathways,62 and
conditional knockout of the TOR1A gene revealed relatively selective
degeneration of cerebellar pathways.63 The hippocampus also appears
to be abnormal.64,65 Because the anatomical and functional studies of
the DYT1 models have revealed abnormalities in multiple brain regions,
it has been challenging to know which areas might be most responsible
for causing dystonia. However, one study showed that regional knock-
down of the Tor1a gene only in the cerebellum, but not in the basal
ganglia, was sufficient to cause dystonic movements.66
Summary of recent animal studies. Some of the recent animal studies
imply that dystonia arises from selective dysfunction of the basal
ganglia (e.g., the genetic model for dopa-responsive dystonia or the
Gunn rat model of kernicterus). Other animal models imply that
dystonia arises from dysfunction of the cerebellum (e.g., models
involving Ip3r1 mutations or pharmacologic or genetic manipulations
of cerebellar circuits). Some models imply abnormal interactions
among the basal ganglia and cerebellum (e.g., models of rapid-onset
dystonia–parkinsonism). Together, the results suggest different under-
lying anatomical substrates may be responsible for different types of
dystonia in animals.
The anatomical basis for dystonia: evidence from
non-human primates
Although dystonia also has been described in non-human primates,
published studies are less abundant than those for rodents due to the
technical challenges and costs associated with primate studies.67
Several early studies revealed that toxic lesions68,69 or local pharma-
cological manipulations of the putamen or its connections70,71 could
induce dystonia in normal primates. To date, there are no publications
describing dystonia following manipulations of the cerebellum in
primates.
However, several studies have implicated other brain regions.
For example, one study described abnormal head movements resembl-
ing human cervical dystonia following manipulations of the superior
colliculus in macaques.72 In another series of studies, abnormal head
movements resembling human cervical dystonia were induced fol-
lowing selective manipulations of the midbrain interstitial nucleus of
Cajal in macaques.73–76 This region is interconnected with both the
basal ganglia and the cerebellum, placing it at a location where it can
interface with both regions.16 Interestingly, the interstitial nucleus of
Cajal is the same region that served as a target for stereotactic surgical
treatments for cervical dystonia more than 30 years ago.77
The anatomical basis for dystonia: evidence from humans
Historical perspective and lesion studies. Historically, dystonia was
viewed as a psychiatric disorder. An organic basis was not widely
accepted until the publication of a series of papers linking it with focal
lesions of the nervous system, particularly the basal ganglia.78 Sub-
sequent studies described focal lesions in many regions of the nervous
system. A summary of individual case reports can be found in prior
reviews,9,17 and the largest series are summarized in Table 2. The
earliest of these series focused on hemidystonia.79,80 In hemidystonia,
the majority of lesions affected the basal ganglia, and particularly the
putamen. Since then, multiple other studies have addressed cervical
dystonia,81 craniofacial dystonia,82 limb dystonia,83 and series with
mixed populations.84,85 A summary these studies indicates that the
basal ganglia are not the only regions to be affected (Table 2). The
thalamus, cerebral cortex, cerebellum, and brainstem are frequently
involved in other types of dystonia.
Although studies of focal lesions have traditionally played a very
important role in clinical neurology, a well-known limitation is that it is
very difficult to prove a causal relationship between the lesion and the
clinical disorder. Another caveat is that the earliest studies from the
1980s relied mostly on CT, which has poor sensitivity for small lesions
(e.g. thalamus) and those in the posterior fossa (e.g. cerebellum and
brainstem). As a result, the early studies likely underestimated the
contributions from certain types of lesions in some regions.
Modern imaging studies. In routine clinical imaging studies, the vast
majority of patients with dystonia lack overt lesions. However,
experimental imaging methods involving positron emission tomogra-
phy or MRI have revealed subtle quantitative abnormalities for many
types of dystonia. Multiple MRI-based studies have been reported
Jinnah HA, Neychev V, Hess EJ Motor Network Model for Dystonia
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services4
including voxel-based morphometry (VBM), diffusion tensor imaging
(DTI), resting state (rsMRI), or functional MRI (fMRI). These imaging
studies have been reviewed several times,9,13,86,87 including one meta-
analysis for VBM.88 Several conclusions have emerged. First, abnor-
malities can be detected in multiple brain regions including the basal
ganglia, cerebellum, cortex, and others. Second, connectivity between
these regions is often abnormal. Third, the regions affected across
these studies are similar, but not always consistent. Fourth, it is chal-
lenging to discriminate regions that cause dystonia from regions that
may show secondary changes.
To illustrate these points, the results from VBM are summarized in
Table 3. This method has revealed abnormalities in several brain
regions. However, the results are not consistent across studies, even
when evaluated according to different types of dystonia. For example,
the sub-regions affected within the basal ganglia or the cerebellum are
not always the same. In some cases, the direction of changes (increased
or decreased volume) is different even within the same brain region.
The reasons for these discrepancies are not clear, but they may reflect
different patient populations studied, different procedures for data
acquisition, or different methods for data analysis. Whatever the reasons,
the inconsistencies have led to concerns regarding the generalizability of
conclusions from individual studies, especially those with relatively small
numbers of cases.
Another challenge has been the discrimination of brain abnormal-
ities that cause dystonia from those that are compensatory or a con-
sequence of dystonia. Even for normal individuals, suppression of
movements (e.g., immobilization restraint) or augmentation of move-
ments (e.g., training) both alter brain microstructure, and the changes
can be measured via VBM.89,90 For example, professional musicians
and golfers both have subtle changes in regional brain volumes that
can be detected via VBM.91,92 In addition, brain abnormalities repor-
ted for dystonia change dynamically following botulinum toxin treat-
ment.93–96 One study revealed significant abnormalities by fMRI
among patients with psychogenic dystonia.97 Taken together, these
studies imply that at least some of the abnormalities detected via these
methods are a consequence of dystonia, not a cause for it.
Overall, the human imaging studies are provocative because they
reveal changes in the brains of patients with dystonia. The results can
be interpreted in support of the concept that dystonia is a network
disorder, because they have revealed changes in several nodes of the
network, or in the functional connectivity between the nodes. However,
the results do not provide conclusive evidence for a causal role for any
specific brain region because it is impossible to establish whether the
changes reflect a cause or consequence of abnormal movements.
Behavioral studies. The motor network model has also stimulated
multiple behavioral studies of dystonia. These studies are driven by the
concept of association; if dystonia results from abnormalities of the
basal ganglia or cerebellum, then it should be possible to find other
evidence that these regions are abnormal. For example, dystonia and
parkinsonism frequently occur together. Dystonia in Parkinson’s
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Table 3. Voxel-based Morphometry Studies of Dystonia
Type of
Dystonia
Study Cases/Controls Regions Affected
BG CRB CTX Other
BSP Etgen et al.148 16/16 Put (q) IPL (Q)
BSP Obermann et al.149 11/14 Caud (q) Hem (q) Thal (Q)
Put (Q)
BSP Martino et al.150 25/24 PreF (q)
SMC (Q)
STL (Q)
BSP Suzuki et al.151 32/48 SMC (q)
Cing (q)
CCD Piccinin et al.152 35/35 Verm (q)
Hem (Q)
CCD Piccinin et al.153 27/54 Verm (Q) IPD (Q) HPC (Q)








CD Egger et al.155 11/31
CD Obermann et al.149 9/14 Caud (q) Hem (q) STL (q) Thal (q)
Put (Q)
CD Draganski et al.156 29/28 Put (q)
GP (q)
CD Pantano et al.157 19/28 Caud (Q) PM (Q)
Put (Q) SMC (Q)





Jinnah HA, Neychev V, Hess EJ Motor Network Model for Dystonia
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services6
of levodopa treatment.98–100 Dystonia and parkinsonism are also
combined in a number of inherited disorders associated with damage
or dysfunction of the basal ganglia including dopa-responsive dystonia,
neurodegeneration with brain iron accumulation, Wilson’s disease,
and others.2,101 These clinical observations highlight connections
between dystonia and the basal ganglia dysfunction.
Dystonia also frequently occurs in association with disorders of the
cerebellum. It can be a presenting feature, the only feature, or the
predominant feature for several of the spinocerebellar ataxias9,102 and
several other inherited disorders that primarily affect the cerebel-
lum.2,103 Although most patients with idiopathic adult-onset dystonia
do not have overt ataxia,14 many have a tremor that resembles
essential tremor,104,105 which has been linked with dysfunction of
cerebellar circuits. In a recent retrospective review of 188 patients with
cervical dystonia, 26 had abnormalities of the cerebellum on routine
clinical imaging studies, and 10 were thought to have had cerebellar
signs on examination.106 Quantitative studies of the gait have also
revealed subclinical problems with balance and stepping.107,108 These
clinical observations highlight connections between dystonia and the
cerebellar dysfunction.
Collectively, these observations are useful because they show that
various types of dystonia may be linked with additional clinical features
typically associated with the basal ganglia or cerebellum. However, they do
not provide causal evidence regarding anatomical localization of dystonia.
Other experimental paradigms have been explored to reveal abnor-




Study Cases/Controls Regions Affected
BG CRB CTX Other
CD Bono et al.159 19/25 PM (Q)
PMC (Q)
CD Waugh et al.160 17/17
CD Filip et al.161 25/25 Verm (q) PMC (q)
Hem (q)
DYT1 Draganski et al.156 11/11 Put (Q)
FHD Garraux et al.162 36/36 SMC (q)
FHD Egger et al.155 11/31 GP (q)
FHD Delmaire et al.163 30/30 Hem (Q) SMC (Q) Thal (Q)
FHD Granert et al.89 14/14 PM (q)
FHD Granert et al.164 11/12 Put (q)
FHD Zeuner et al.165 22/28 GP (q)
Put (q)
GEN Egger et al.155 9/31 GP (q)
LD Simonyan et al.166 40/40 Put (q) Hem (q) SMC (q)
PreF (q)
LD Waugh et al.160 7/7
Arrows show increased (q) or decreased (Q) volumes. Studies involving multiple types of dystonia are separated according to type of dystonia
rather than as a mixed group.
Abbreviations: Caud, Caudate; CCD, Craniocervical Dystonia (a mixed population of cranial dystonia, cervical dystonia and both combined); Cing,
Cingulate Gyrus; DLPFC, Dorsolateral Prefrontal Cortex; Floc, Cerebellar Flocculus; GEN, Generalized Dystonia; GP, Globus Pallidus; Hem,
Cerebellar Hemisphere; HPC, Hippocampus; IPL, Inferior Parietal Lobule; Pref, Prefrontal Cortex; NA, Nucleus Accumbens; OFC, Orbitofrontal
Cortex; OCC, Occipital Cortex; PM, Primary Motor Cortex; Put, Putamen; SMC, Sensorimotor Cortex; STL, Superior Temporal Lobe; SMA,
Supplementary Motor Area.
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Because the contributions of the basal ganglia in dystonia have been
accepted for many years, most of the recent studies have focused
instead on the cerebellum. One paradigm is the classical conditioned
eye blink reflex, which is dependent on cerebellar circuits.109,110 In this
paradigm, an apparatus is used to deliver a gentle puff of air to the
cornea to stimulate an eye blink. If the puff is repeatedly preceded by
a sound, normal people begin to blink following the sound, even with
no air puff. This reflex is abnormal among patients with adult-onset
cervical or limb dystonia,111,112 a phenomenon that may be predicted
by co-existing tremor.113 This reflex is also abnormal in patients with
isolated segmental dystonia or DYT11 dystonia.6,114 It is not abnormal
among those with DYT1 or DYT6 dystonia, or dystonia acquired
from brain injury.6,115,116
The cerebellum also plays a key role in other forms of motor
adaptation (motor learning). Tasks that involve adaptation of saccades
are abnormal in patients with DYT11,114 but not adult-onset cervical
dystonia.117 Adaptation of hand tasks is abnormal in patients with
writer’s cramp,118 but not cervical dystonia.117,119 Tasks that require
adaptation of the gait are abnormal in blepharospasm and hand
dystonia, but not cervical dystonia.120
These behavioral studies are provocative because they imply that
cerebellum-dependent motor learning may be abnormal in some types
of dystonia but not others. Some investigators have interpreted the
results in support of the concept that cerebellar dysfunction contributes
to dystonia. Others favor the interpretation that these ‘‘cerebellar’’
abnormalities reflect indirect consequences of basal ganglia dysfunc-
tion. All of these studies must be interpreted with caution, because
results vary according to subtype of dystonia and task, and most were
conducted with very small numbers of cases. It is not feasible to
extrapolate findings from one task in one type of dystonia to make
generalizations regarding all types of dystonia, because the underlying
anatomical mechanisms may be different for different subtypes of
dystonia.6 A more important limitation is that these types of studies
are based on the concept of ‘‘guilt by association’’ and do not pro-
vide unequivocal evidence for a causal role for any brain region in
dystonia.
Interventional studies. In principle, interventional studies have greater
potential for establishing causal links between specific brain regions
and dystonia. Observations that pallidotomy or DBS of the internal
segmental of the globus pallidus (GPi) are effective in treating many
forms of dystonia have been cited as evidence for involvement of
abnormal basal ganglia signaling for many years. An important caveat
is that some types of dystonia respond very well, while others do
not.121–124 These observations reinforce the concept that different
anatomical substrates are important different types of dystonia.
Before DBS was widely used for dystonia, it was common for sur-
geons to explore the effects of lesions in different brain regions.125–127
The cerebellum and thalamus were frequent targets, but fell out of
favor because results were inconsistent. Some patients responded very
well, while others derived no benefit. The motor network model has
encouraged a re-evaluation of these older studies, based on the idea
that some subtypes of patients may respond best to interventions
involving the basal ganglia while others may respond to interventions
involving the cerebellum. For example, there has been increasing
interest in thalamotomy or DBS of the thalamus. Some of these studies
have targeted the ventral intermediate nucleus of the thalamus (which
receives cerebellar afferents) or the ventral oralis anterior nucleus
(which receives pallidal afferents), or both combined.128–133 Some
dystonia patients seem to respond best to procedures targeting one
region over another region.
Another example is that stimulation of the anterior lobe of the
cerebellum or stereotactic lesions of the deep cerebellar nuclei have
been used for many years in cerebral palsy to reduce excessive muscle
tone and abnormal movements, which often reflect a combination of
spasticity and dystonia. Recent studies have attempted to dissect
whether the benefits of these procedures are related to reductions in
spasticity or dystonia.134,135 The observations imply that interrupting
abnormal basal ganglia or cerebellar signaling may provide effective
therapy for dystonia. However, larger and more methodical studies are
needed to determine optimal surgical targets for different subtypes of
dystonia.
Another intervention that has proven useful in exploring the
anatomical substrates for dystonia is transcranial magnetic stimulation
(TMS). Because the magnetic stimuli penetrate only the most super-
ficial parts of the brain and do not reach the basal ganglia, TMS has
been used to address contributions of the cerebral cortex and cere-
bellum. Numerous studies have been conducted, and they have been
the focus of several recent reviews.10,17,136–138 Here we summarize
only the interventional studies reporting TMS effects on dystonic
movements.
A randomized sham-controlled study involving 1 Hz repetitive TMS
(theta burst stimulation) over the cerebellum for 2 weeks produced
a small but significant decrease (–15%) in Toronto Wester Spasmodic
Torticollis Rating Scale (TWSTRS) motor scores in 20 patients with
cervical dystonia.139 Another sham-controlled study involving a similar
cerebellar TMS paradigm for 10 weeks combined with physical ther-
apy also produced small but significant decreases (–10%) in TWSTRS
motor scores and improvements in quality of life measures in 16 patients
with cervical dystonia.140 These studies are provocative because they
imply that interventions involving the cerebellum may influence dystonic
movements. On the other hand, a randomized sham-controlled study
revealed no benefits after a single session of 1 Hz repetitive TMS over
the cerebellum in 10 patients with writer’s cramp.141 A related study
using a similar single-session paradigm showed no changes in the
kinematics of abnormal movements for 13 patients with cervical dystonia
and 13 with hand dystonia.142 It remains to be determined whether the
different outcomes reflect differences in the dystonia populations studied
or other factors in study design such as duration of TMS.
Translational neuroscience and dystonia
Translational science. ‘‘Translational neuroscience’’ refers to the stra-
tegy of applying knowledge learned from simpler experimental con-
ditions to more complex ones. For translational medicine, this often
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means conducting experiments first in animals, and subsequently
evaluating relevance for humans. The major benefits of starting with
animals include the ability to conduct studies rapidly and efficiently in
tightly controlled experimental settings, and the opportunity to perform
direct experimental manipulations that cannot be done in human
subjects.
Rodents have emerged as one of the most popular species in
biomedical research, because they are inexpensive, easy to work with,
and have sufficient biological similarities to humans for many experi-
mental goals. A major attraction of rodents is that efficient methods
have been developed to precisely manipulate specific biological targets,
in ways that can be limited to specific brain regions or neuronal
subtypes.27,36,143 An important limitation is that species differences
may limit applicability to humans. As a result, these species limitations
must be carefully considered.
Species differences in motor behavior. An obvious difference between
rodents and humans is their normal motor behavior. These differences
lead to a fundamental question regarding whether or not specific
movement disorders, such as dystonia, can occur in rodents. Dystonia
is defined by its characteristic movements,1 most notably excessive
involuntary muscle contractions leading to movements that are exces-
sively forceful or repetitive. Muscle contractions in dystonia often
spread to nearby muscles, leading to twisting movements, abnormal
postures, and sometimes co-contraction of antagonist muscles. By
definition, any movements with these clinical characteristic qualities
can be called ‘‘dystonic’’. Electromyography (EMG) can be used to
verify the electrophysiological characteristics of dystonic movements,144
but these characteristics are not considered diagnostic.
Abnormal movements fitting the clinical and EMG criteria used
to define dystonia occur in several species. They have been reported
in the veterinary literature for rodents, cats, dogs, horses, birds, and
other species. Dystonic movements also have been reported in the
biomedical research literature for rodents,27,143 cats,145,146 and non-
human primates.67 Several of these studies included video recordings
demonstrating the abnormal movements, sometimes with EMG veri-
fication of the characteristic hallmarks of dystonia. Of course, some
types of dystonia, such as writer’s cramp, are very unlikely to be
reproducible in species such as rodents.
Skeptics of animal models sometimes question whether dystonic
movements reported for rodents reflect ‘‘real’’ dystonia. The implica-
tion of this question is that some types of dystonia are real and some
are not. However, dystonia is defined by the nature of abnormal move-
ments, so the more relevant question is not whether dystonic move-
ments are ‘‘real’’, but whether the mechanisms responsible for dystonia
are shared across species. In other words, is there any evidence that
biological mechanisms causing dystonia differ among species?
Species differences in anatomical pathways. The brains of rodents and
humans are obviously quite different. The rodent brain is much
smaller and simpler than the human brain.147 The most obvious
differences are at the macroscopic level. The corticospinal motor
pathways in rodents are simpler than those of humans. In rodents,
the cortex is less clearly subdivided into specific functional domains,
and the laminar organization of the cortex is simpler than in humans.
For basal ganglia pathways, the rodent brain is again simpler than the
human brain. For example, the caudate and putamen are separate
structures in humans but combined into a single structure (caudoputa-
men) in rodents. Further, the basal ganglia in humans are functionally
and somatotopically organized into multiple discrete but partially over-
lapping parallel pathways, which are absent in rodents. For cerebellar
pathways, the main differences between rodents and humans again
exist at the macroscopic level with differences in size and relative
proportions of different subregions.
Despite these differences, there are numerous similarities. Histolo-
gically, for all three major motor pathways, the major neuronal sub-
types and their morphologies are very similar across rodents and
humans. Their neurotransmitter phenotypes and post-synaptic signal
transduction pathways are similar too. Intrinsic connectivity is quite
similar across species too. For example, for both species, cerebellar
circuitry is remarkably stereotyped with a very ordered arrangement of
climbing fibers, mossy fibers, parallel fibers, and Purkinje neuron
output. The major afferents and efferents to each region are similar
too, although they differ in proportions.
The goal of translational neuroscience. Skeptics uncomfortable with
translational sciences are often quick to emphasize the behavioral and
anatomical differences between rodents and humans. On the other
hand, there are many similarities. For translational neuroscience,
cataloging the similarities and differences is less relevant than whether
these anatomical differences preclude the use of rodents for dystonia
research. Rodents have been used very successfully for studying other
neurological disorders such as Parkinson’s disease, tremor, Huntington’s
disease, and spinocerebellar ataxias. A research toolkit that is limited to
humans or primates would severely restrict progress in dystonia.
The value of rodent models is not related to how closely they
resemble humans. Instead, their value lies in how effectively they can
point to novel insights and guide studies in humans. Findings from
rodents can be re-evaluated in humans, or at least in non-human
primates, and either discarded as irrelevant, or exploited to generate
novel insights. The strong evidence regarding the role of the cere-
bellum in rodents with dystonia has already stimulated numerous
recent human studies looking at the cerebellum. Judging from the
number of recent human studies that so far appear to validate the
motor network model developed via studies of animals, the process of
translation is well under way. The human studies are often incon-
clusive because of the nature of experimental interventions that can be
applied in humans. The most valuable aspect of translational neuro-
science may be the development of novel treatments that take the new
evidence into account. Some investigators have already called for more
methodical studies of direct interventions of cerebellar circuits, based
on rodent studies showing that deep brain stimulation of cerebellar
circuits can reduce dystonia.77 The motor network model provides the
biological framework in which the results of these studies can be
interpreted.
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Conclusions
The motor network model posits that all subtypes of dystonia are
not the result of dysfunction of a single brain region. Instead, different
brain regions are involved in a motor network that includes the basal
ganglia, cerebellum, thalamus, and cortex. For different types of dystonia,
the starting point may be different.
The motor network model has received strong support from
numerous animal studies, which have provided unequivocal evidence
that certain subtypes of dystonia may originate from dysfunction in
the basal ganglia, cerebellum, or both combined. Similar evidence has
begun to emerge from human studies, although the results are not
conclusive because of the limits of the types of experimental interven-
tions that can be applied in humans.
The anatomical heterogeneity underlying dystonia has only recently
been appreciated. Until this heterogeneity is better understood, it is
important to avoid making overly generalized conclusions about all
forms of dystonia from studies of a single subtype. Considering the
remarkable clinical heterogeneity of dystonia, a related heterogeneity
of the underlying anatomical substrates is not surprising. A better
understanding of this heterogeneity may be used to guide developing
novel treatment strategies.
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